Lupine Publishers-Journal of Hepatology Research
Advanced Hepatocellular Carcinoma in A ScottishPopulation – Current Experience and the Future by Baxter MA in Current Trends in Gastroenterologyand Hepatology in Lupine Publishers
Sorafenib is the current first line standard of care in patients with advanced hepatocellular carcinoma (HCC). Several other drugs are emerging as efficacious agents in this setting. This article will outline our current real-world experience with sorafenib in a Scottish population as well as discuss the evidence behind new potential therapies in Lupine Publishers.
For more information, please go through the below links
https://lupinepublishers.com/gastroenterology-hepatology-journal/fulltext/advanced-hepatocellular-carcinoma-in-a-scottish-population-current-experience-and-the-future.ID.000112.php
https://lupinepublishers.com/gastroenterology-hepatology-journal/pdf/CTGH.MS.ID.000112.pdf
https://lupinepublishers.com/gastroenterology-hepatology-journal/abstracts/advanced-hepatocellular-carcinoma-in-a-scottish-population-current-experience-and-the-future.ID.000112.php
For more Lupine Publishers Open Access Journals Please visit our website:http://www.lupinepublishers.com/
For more Gastroenterology open access journal, articles Please Click Here: https://lupinepublishers.com/gastroenterology-hepatology-journal/index.php
Comments
Post a Comment